Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nicotinic acetylcholine receptor subunit alpha 6 (nAChRα6) is a critical component of the insect central nervous system, forming part of the pentameric ligand-gated ion channels that mediate fast excitatory synaptic transmission (UniProt: P0CI92). In Drosophila melanogaster and many other insect species, this specific subunit is the primary molecular target for the spinosyn class of insecticides, including spinosad and spinetoram (PubMed: 22532075). These compounds bind to the receptor, causing continuous activation and over-excitation of the nervous system, which results in paralysis and eventual death of the pest (PubMed: 17030321). Because nAChRα6 is not essential for insect viability under laboratory conditions, it is a frequent site for mutations that confer high-level resistance to spinosyns (PubMed: 26063468). Such resistance often involves gene deletions, premature stop codons, or mis-splicing that leads to the loss of functional alpha 6 subunits (PubMed: 25510395). Understanding the structure and function of this receptor is vital for managing insecticide resistance and developing new crop protection strategies.
Spinosyns act as allosteric activators of the nicotinic acetylcholine receptor alpha 6 subunit, causing prolonged activation of the channel, leading to involuntary muscle contractions, paralysis, and death of the insect (PubMed: 22532075).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinic acetylcholine receptor subunit alpha 6 (nAChRα6).